We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Placenta Stem Cells Could Help Repair the Mothers' Heart

By HospiMedica International staff writers
Posted on 23 Nov 2011
Stem cells from the placenta can travel to injured tissues in the mother's heart during pregnancy and create new cardiac cells, according to a new study.

Researchers at Mount Sinai Medical Center (MSMC; New York, NY, USA) induced heart attacks in pregnant mice and then checked to see if the fetal cells had transferred to the mother. More...
To make the fetal cells easy to spot, they were genetically tagged with green fluorescent protein (GFP). The researchers found that the fetal cells selectively and specifically migrated to the injured zone of the maternal hearts, and not to noninjured organs within the same mouse. Two weeks after the animal's induced heart attack, fetal cells comprised 2% of the maternal heart; furthermore, the fetus-derived cells differentiated into heart muscle cells and cells that form blood vessels or the endothelial lining of blood vessels and other organs.

The cells could similarly differentiate when isolated from the mother's heart and grown in Petri dishes, even forming beating cardiac cells in culture. About 40% of the fetal cells that incorporated into the mothers' hearts expressed Cdx2, a marker of trophoblast stem cells, which form when embryonic stem cells develop; though embryonic stem cells lead to all the cell types in fetus, trophoblast stem cells give rise to the placenta.

The researchers are now conducting lineage-tracing experiments to confirm the precise origin of the cells. The nonexpressing cells (60%) could still be from the placenta, and may have switched off Cdx2 or other early progenitor markers and differentiated into cardiac cell types. The study was presented at the American Heart Association (AHA) Scientific Sessions 2011, held during November 2011 in Orlando (FL, USA).

“If we can confirm that trophoblast stem cells are directly involved in mediating cardiac repair in the injury state, then we may just have found that elusive cell type, other than the embryonic stem cell, that can truly become a beating heart muscle cell,” said senior author and study presenter cardiologist Hina Chaudhry, MD. “You could bank placentas and isolate stem cells and potentially use them in other individuals and not just for peripartum cardiomyopathy, but for a broad spectrum of heart diseases.”

The placenta is an organ that connects the developing fetus to the uterine wall to allow nutrient uptake, waste elimination, and gas exchange via the mother's blood supply. The placenta functions as a fetomaternal organ with two components: the fetal placenta (Chorion frondosum), which develops from the same sperm and egg cells that form the fetus, and the maternal placenta (Decidua basalis), which develops from the maternal uterine tissue.

Related Links:
Mount Sinai Medical Center



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.